Business ❯Pharmaceuticals ❯Bristol Myers Squibb

Acquisitions

Karuna Therapeutics RayzeBio Inc.

Bristol Myers Squibb Acquires RayzeBio for $4.1 Billion

Bristol Myers Squibb Acquires Karuna Therapeutics in $14 Billion Deal